Trials / Not Yet Recruiting
Not Yet RecruitingNCT07459556
A Prospective Study of Stapokibart Injection in Patients With Seasonal Allergic Rhinitis (SAR)
A Prospective Study of Stapokibart Injection in Patients With SAR
- Status
- Not Yet Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 400 (estimated)
- Sponsor
- Chengdu Kangnuoxing Biopharma,Inc. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study is an open label, prospective study to evaluate the safety of Stapokibart Injection in subjects with SAR.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | Stapokibart | subcutaneous injection |
Timeline
- Start date
- 2026-03-01
- Primary completion
- 2027-12-01
- Completion
- 2028-02-01
- First posted
- 2026-03-09
- Last updated
- 2026-03-09
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT07459556. Inclusion in this directory is not an endorsement.